Kahyaoglu Sut, HaticeKucukkaya, Burcu2024-06-122024-06-1220210031-59901744-6163https://doi.org/10.1111/ppc.12627https://hdl.handle.net/20.500.14551/18624Purpose This study aimed to assess the prevalence of anxiety and depression and related factors in pregnant women during the coronavirus disease 2019 (COVID-19) pandemic. Design and Methods This cross-sectional study was conducted on 403 pregnant women using a web-based survey. The hospital anxiety and depression scale was used to measure anxiety and depression. Findings The prevalence of anxiety and depression was 64.5% and 56.3%, respectively. Working status, physical activity status, discomfort with hospital visits, having information about COVID-19, and being informed by healthcare workers about COVID-19 were factors related to anxiety (p < .05). Education level, physical activity status, discomfort with hospital visits, and having information about COVID-19 were factors related to depression (p < .05). Practice Implications The aforementioned factors should be considered for reducing anxiety and depressive symptoms during pregnancy.en10.1111/ppc.12627info:eu-repo/semantics/openAccessAnxietyCoronavirusCOVID-19DepressionPregnantMental-HealthArticle572860868Q2WOS:0005732198000012-s2.0-8509160599032989798Q2